TNFRSF9 and B-cell chronic lymphocytic leukemia: CAR T cells from both CLL and ALL patients exhibited strong activation, as indicated by the co‐expression of the early activation marker CD69 and the antigen‐specific activation marker CD137 (Figure 3A).